Pharmacologic Approaches in the Management of Neuropsychiatric Symptoms (NPS) in Alzheimer’s Disease (AD)
Most national organizations (AAGP, AGS, APA, NICE, and Alzheimer’s Association) recommend the judicious use of pharmacologic options when nonpharmacologic interventions have not been sufficiently successful in addressing NPS in AD.